The long-term objectives of this program are to identify the immunogenetic mechanisms, possible etiologic agent(s) and the natural history of the interplay of autoimmunity and the islets of Langerhans, as it relates to the pathogenesis of insulin dependent diabetes (IDDM). This information may be useful in developing immunologic and genetic predictors of individuals with high risk for the eventual development of IDDM, and may allow for the identification of potential environmental factors that might precipitate an ongoing defect in autoimmunity in such individuals. Such cause and effect identifications might then permit for appropriate support of beta cell function on one hand and the targeting of specific preventive immunotherapies on the other. The basic approach to understanding this problem has been longitudinal studies in sets of monozygotic twins discordant for IDDM. An important part of the program since its inception in 1964 has been the preservation of biologic materials (frozen serum samples) from each and every encounter. A second factor has been the performance of in-depth perturbation of the function of the endocrine pancreas serially two to three times a year. Methods have been developed and refined allowing the detailed quantification of the early phase insulin release (to multiple secretagogues) and it has been discovered that a slow progressive loss of beta cell function occurs several years prior to the development of overt clinical IDDM. Several qualitative and quantitative markers for autoimmunity and beta cell destruction have been developed and validated. This proposal envisions the continuation into the 23rd and subsequent years of the prospective monozygotic twin-IDDM pathogenesis study. In addition to the periodic evaluation of the currently enrolled discordant and concordant twins, recruitment and study of new twin pairs will be intensified. Focus will be directed towards the characterization of the pathogenetic events and processes surrounding the initiation of abnormal islet cell autoimmunity (e.g., conversion from autoantibody-negativity to positivity) and beta cell dysfunction in the currently discordant twins. Studies to further define genetic/immunogenetic mechanisms and to develop novel predictive serologic and cellular immunoassays will be continued. Finally, this model investigative system of monozygotic twins will be extended to other groups (e.g., non-diabetic first degree relatives) also at higher risk for the development of IDDM.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK033790-08
Application #
3232182
Study Section
Metabolism Study Section (MET)
Project Start
1984-04-01
Project End
1992-03-31
Budget Start
1990-06-20
Budget End
1991-03-31
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
Schools of Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Pugliese, A; Solimena, M; Awdeh, Z L et al. (1993) Association of HLA-DQB1*0201 with stiff-man syndrome. J Clin Endocrinol Metab 77:1550-3
Gianani, R; Pugliese, A; Bonner-Weir, S et al. (1992) Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41:347-53
Vardi, P; Crisa, L; Jackson, R A (1991) Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 34:93-102
Ziegler, R; Alper, C A; Awdeh, Z L et al. (1991) Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes. Diabetes 40:709-14
Ziegler, R; Jackson, R A; Ziegler, A G et al. (1990) Type I diabetes: polygenic inheritance, multiple autoantigens and 'dual' parameter prediction. J Autoimmun 3 Suppl 1:69-74
Ziegler, A G; Herskowitz, R D; Jackson, R A et al. (1990) Predicting type I diabetes. Diabetes Care 13:762-5
Bleich, D; Jackson, R A; Soeldner, J S et al. (1990) Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes. Diabetes Care 13:111-8
Karasik, A; O'Hara, C; Srikanta, S et al. (1989) Genetically programmed selective islet beta-cell loss in diabetic subjects with Wolfram's syndrome. Diabetes Care 12:135-8
Ziegler, A G; Ziegler, R; Vardi, P et al. (1989) Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 38:1320-5